-
Mashup Score: 0Another OpenAI employee announced she quit over safety concerns hours before two exec resigned - 1 year(s) ago
Gretchen Kruger announced in a thread on X on Wednesday that she quit OpenAI on May 14.
Source: www.businessinsider.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4OpenAI holds back public release of tech that can clone someone's voice in 15 seconds due to safety concerns - 1 year(s) ago
The AI firm will preview the tool with early testers but won’t release it widely because of the potential for misuse ahead of the election.
Source: fortune.comCategories: General Medicine News, General HCPsTweet-
.@OpenAI holds back public release of tech that can clone someone’s voice in 15 seconds due to #safety concerns https://t.co/EiEWfgUNCI
-
-
Mashup Score: 3Managing Healthcare Staff with Symptoms of a Respiratory Infection or a Positive COVID-19 Test Result - 2 year(s) ago
Covering the management of healthcare staff with symptoms of a respiratory infection, including COVID-19 and positive COVID-19 test results—updated in August 2022
Source: www.medscape.co.ukCategories: General Medicine News, Latest HeadlinesTweet-
New guidelines for managing respiratory infection symptoms in patient-facing healthcare staff, including COVID-19. Stay informed on what to do if you test positive or have been in close contact with a confirmed case. #COVID19 #healthcare #safety https://t.co/s4W8VMd4bf https://t.co/ntTlqU44RW
-
-
Mashup Score: 2RO-ILS Dosimetry Safety Stars- American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO) - 2 year(s) ago
In recognition of National Medical Dosimetrist Day, RO-ILS solicited nominations and selected three dosimetrists as safety stars for national recognition for their impact in patient safety.
Source: www.astro.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Three dosimetrists were nominated & selected for recognition as RO-ILS #safety stars for National #MedicalDosimetristDay. Learn more about their contributions, & join us in congratulating them: https://t.co/oOEZqvTyYG #MedDosKnowsNoBorders https://t.co/at3zWSGIwX
-
-
Mashup Score: 0UK to host AI safety summit at start of November - 2 year(s) ago
‘Like-minded’ states to be asked to Bletchley Park along with tech executives and academics
Source: www.ft.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#UK to host #AI #safety #summit at start of November | Financial Times https://t.co/N9Jnq1fpYc
-
-
Mashup Score: 0Five-Year Independent Patient-Level Mortality Analysis of the Pooled ILLUMENATE Pivotal and EU Randomized Controlled Trials - 2 year(s) ago
There is a need to evaluate the latest information regarding a potential late safety signal in patients treated with paclitaxel-coated devices for per…
Source: www.sciencedirect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
🔬In a comprehensive, patient-level meta-analysis of ILLUMENATE Pivotal & EU RCTs, no difference in all-cause mortality between #Stellarex DCB & PTA through 5 yrs. #PAD #Safety ➡️ https://t.co/vZWjrrSpf8 @DrBillGray @drseanlyden @KenOurielMD https://t.co/9moXU44eAq
-
-
Mashup Score: 2Thinkers360 - 2 year(s) ago
Thinkers360 is the world’s first open platform for thought leaders to discover opportunities, promote and advance their expertise. Leading brands use our tools for finding and working with the world’s leading influencers as well as managing and showcasing their own internal experts.
Source: www.thinkers360.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @thinkers360: #Health and #Safety Thought Leader & Influencer Leaderboard (Live) To view or participate (free) https://t.co/DuHTJAGUZD…
-
-
Mashup Score: 0Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial - 2 year(s) ago
AbstractAims. Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure with mildly reduced o
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
News from DELIVER trial: dapagliflozin's safety and efficacy across a wide range of background diuretic use! #dapaglifozin #DELIVER #heart failure #LVEF #safety #efficacy @ESC_Journals @escardio https://t.co/lyS4L8jMtB https://t.co/NOsgeIwPdS
-
-
Mashup Score: 0Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes - 2 year(s) ago
OBJECTIVE. To evaluate the effects of tirzepatide on body composition, appetite, and energy intake to address the potential mechanisms involved in body weight l
Source: American Diabetes AssociationCategories: Cardiologists, Latest HeadlinesTweet-
#Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in #T2D : the new challenger of #GLP1RA. More potent, ongoing data about efficacy on #MACE and #safety https://t.co/4yAnKzcdgz
-
-
Mashup Score: 4Low levels of low-density lipoprotein cholesterol, intracerebral haemorrhage, and other safety issues: is there still a matter of debate? - 2 year(s) ago
Abstract. Although some observational studies suggest a potential association of low levels of low-density lipoprotein cholesterol (LDL-C) with intracerebral ha
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Low levels of low-density lipoprotein cholesterol, intracerebral haemorrhage, and other safety issues: is there still a matter of debate? #LDL #ICH #Safety #ResidualRisk https://t.co/iJTa2GM43X
-
Another @OpenAI Employee Quits Over #Safety Concerns https://t.co/F33sB8MlRT